SAVIMS

Viral illnesses

Monkeypox, Other scientific evidence, Resource Type, Vaccine effectiveness, Vaccine safety & adverse events, Vaccines, Viral illnesses

Concerns Over Emergency Monkeypox Vaccine Rollout in Africa

Reference: SA Vaccine Injury Medco-Legal Study Group – SAVIMS. (2024, August 18). Statement on proposed emergency roll-out of vaccine program in Africa for monkeypox. Johannesburg, South Africa. Retrieved from www.savims.org.za Summary: The SA Vaccine Injury Medco-Legal Study Group (SAVIMS) has expressed significant concerns regarding the proposed emergency rollout of monkeypox vaccines in Africa, as announced […]

COVID-19, Reference Library

Early Ambulatory Multidrug Therapy Procter McCullough

Summary This study examined early ambulatory multidrug therapy for high risk COVID 19 patients to reduce hospitalisation and death rates. The research included 869 cases, with 320 cases from April to September 2020 and 549 cases from September to December 2020. The treatment protocol involved antiviral agents, antibiotics, inhaled medications, and intravenous supplements. In the

COVID-19, Reference Library

UK Vaccine Report Week 42

Summary The latest UK COVID 19 vaccine surveillance report for week 42 shows various vaccines are effective against symptomatic disease, especially the Delta variant. Vaccination coverage is high in older age groups, with reduced transmission risk and lower rates of cases, hospitalisations, and deaths in vaccinated individuals. The report also includes data on emergency care

COVID-19, Reference Library

FLCCC I MASK Plus Protocol

Summary The document outlines the I MASK+ Protocol for COVID 19 prevention and early outpatient treatment, including the use of ivermectin and other medications, as well as general preventive measures like wearing masks and hand hygiene. It emphasises the importance of vaccines and early treatment in consultation with healthcare providers. The protocol includes dosing guidelines,

COVID-19, Reference Library

Comprehensive investigations revealed consistent pathophysiological alterations after vaccination

Summary The study examined immune responses following vaccination with inactivated SARS CoV 2, revealing alterations in gene expression in immune cell types. These changes included heightened NF κB signalling and reduced type I interferon responses, resembling patterns seen in COVID 19 patients. Clinical laboratory findings post vaccination showed electrolyte imbalances, coagulation profile shifts, and renal

COVID-19, Reference Library, SAVIMS Publications

Pfizer vaccine Effects Herve Seligmann Evaluation

The document by Hervé Seligmann evaluates the effects of the Pfizer COVID 19 vaccine. It raises concerns about potential adverse effects and the adequacy of clinical trial data. The analysis suggests that there may be underreporting of negative outcomes and emphasises the importance of comprehensive post vaccination monitoring to ensure safety and efficacy. The report

Scroll to Top